Key result
Type 2 Diabetes Mellitus in patients undergoing TAVR was associated with higher risks of all-cause mortality, MACCE, and HF exacerbation compared to patients without T2DM.
Why the study?
Does Type 2 Diabetes Mellitus worsen clinical outcomes in patients undergoing transcatheter aortic valve replacement?
Cohort
Yes
Does Type 2 Diabetes Mellitus worsen clinical outcomes in patients undergoing transcatheter aortic valve replacement?
Answers are grounded in this paper and cite their sources.
The presence of Type 2 Diabetes Mellitus is associated with significantly worse clinical outcomes and higher resource utilization following TAVR.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2026) conducted a cohort in Transcatheter Aortic Valve Replacement. Type 2 Diabetes Mellitus vs. Patients without Type 2 Diabetes Mellitus was evaluated on All-cause mortality, MACCE, and HF exacerbation. Type 2 Diabetes Mellitus in patients undergoing TAVR was associated with higher risks of all-cause mortality, MACCE, and HF exacerbation compared to patients without T2DM.
Synapse has enriched 10 related papers. Consider them for comparative context: